ACR Psoriatic Arthritis RhAPP Up Survey

PODCAST EVALUATION

1.First & Last Name

2.Degree(Required.)

3.Specialty(Required.)

4.Which of the following best summarizes a key finding from the post hoc analysis of guselkumab in patients with active psoriatic arthritis?(Required.)

Patients with prior TNFi exposure were significantly less likely to achieve MCII compared to bio-naïve patients.

Guselkumab treatment every 8 weeks significantly increased the likelihood of achieving MCII across most outcomes compared to placebo.

Baseline disease activity had no effect on the threshold required for a patient to perceive improvement as meaningful.

MCII thresholds were found to be higher in TNFi-naïve patients than in those with prior TNFi exposure.

5.Approximately how many patients per month do you see with PsA?(Required.)

6.The educational activity will enhance my professional effectiveness in treating patients(Required.)

7.The educational activity will result in a change in my practice behavior.(Required.)

8.How will you change your practice as a result of participating in this activity? (Select all that apply.)

Create/revise protocols, policies, and/or procedures

Change the management and/or treatment of my patients

This activity validated my current practice

I will not make any changes to my practice

Other (please explain)

9.This activity improved my ability to perform as a more effective healthcare team member.(Required.)